Related Experiment Video
Updated: Jun 19, 2026
06:32
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
Extrapulmonary small cell carcinoma in breast and prostate
Juan Quirós Rivero1, Julia Luisa Muñoz García, Joaquín José Cabrera Rodríguez
1Radiation Oncology Service, Hospital Universitario Infanta Cristina, Badajoz, Spain. juanquirosrivero@yahoo.com
Summary
Extrapulmonary small cell carcinoma in the breast and prostate are rare and aggressive tumors. These neoplasms resemble lung small cell carcinomas and require treatment tailored to clinical stage.
Area of Science:
- Oncology
- Pathology
Background:
- Extrapulmonary small cell carcinoma (EPSCC) is a rare group of neoplasms.
- EPSCC in the breast and prostate are particularly uncommon.
Observation:
- These tumors are histologically similar to small cell carcinoma of the lung.
- They often present with mixed histology.
- Literature data suggests these are highly aggressive malignancies.
Findings:
- The study details the clinical course and management of two patients with extrapulmonary small cell carcinoma.
- Treatment strategies included surgery, radiotherapy, and chemotherapy, guided by clinical staging.
Implications:
- Highlights the aggressive nature of these rare tumors.
- Emphasizes the need for tailored, stage-based treatment approaches.
- Contributes to the limited case-report-based literature on breast and prostate EPSCC.
